+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Immunodiagnostics Market Report by Product, Technology, Application, End User, and Region 2023-2028

  • PDF Icon


  • 143 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5912118
The global immunodiagnostics market size reached US$ 17.4 Billion in 2022. Looking forward, the market is expected to reach US$ 27.2 Billion by 2028, exhibiting a growth rate (CAGR) of 7.73% during 2022-2028.

Immunodiagnostics refers to an in-vitro diagnostic technology that uses antigen-antibody reaction for the detection of infectious and chronic diseases. It involves the use of radiological, fluorescent or color-forming enzymes and probes for the identification of antibodies that aid in enhancing the targeting range to identify disease progression. Immunodiagnostics also uses various reagents, instruments and software-based solutions for enzyme-linked immunosorbent assay, chemiluminescence, radioimmunoassay and rapid testing. These solutions are widely used for diagnosing diseases, such as cancer and autoimmune, respiratory, endocrine and oncological disorders, along with forensic psychology and environmental and food analysis. As a result, immunodiagnostics finds extensive applications across hospitals, clinical laboratories and research and academic institutes.

Immunodiagnostics Market Trends

The increasing prevalence of chronic medical ailments and infections among the masses is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. There is also an escalating awareness among the consumers regarding the available treatment alternatives for ailments, such as hepatitis B, diabetes and cancer, which is positively impacting the demand for immunodiagnostics kits, assays and analyzers. Additionally, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market toward growth. These advanced point-of-care testing (POCT) systems offer enhanced diagnostic facilities for sepsis, acute cardiac infractions and other medical disorders with higher mortality rates. Other factors, including the increasing requirement for personalized medicines among the masses, along with extensive improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global immunodiagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, technology, application and end user.

Breakup by Product:

  • Reagents
  • Instruments
  • Software and Services

Breakup by Technology:

  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Fluorescent Immunoassay
  • Radioimmunoassay
  • Rapid Test

Breakup by Application:

  • Infectious Diseases
  • Oncology and Endocrinology
  • Hepatitis and Retrovirus
  • Bone and Mineral
  • Autoimmunity
  • Cardiac Biomarker

Breakup by End User:

  • Hospitals
  • Clinical Laboratories
  • Academic and Research Centers
  • Pharmaceutical and Biotechnology Industry

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arkray Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Immunodiagnostic Systems Holdings PLC, Johnson & Johnson, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. How big is the global immunodiagnostics market?
2. What is the expected growth rate of the global immunodiagnostics market during 2023-2028?
3. What are the key factors driving the global immunodiagnostics market?
4. What has been the impact of COVID-19 on the global immunodiagnostics market?
5. What is the breakup of the global immunodiagnostics market based on the application?
6. What is the breakup of the global immunodiagnostics market based on the end user?
7. What are the key regions in the global immunodiagnostics market?
8. Who are the key players/companies in the global immunodiagnostics market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Immunodiagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Technology
7.1 Enzyme-Linked Immunosorbent Assay
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Chemiluminescence Immunoassay
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Fluorescent Immunoassay
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Radioimmunoassay
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Rapid Test
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Infectious Diseases
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oncology and Endocrinology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hepatitis and Retrovirus
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Bone and Mineral
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Autoimmunity
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Cardiac Biomarker
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinical Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Academic and Research Centers
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Pharmaceutical and Biotechnology Industry
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States Market Trends Market Forecast
10.1.2 Canada Market Trends Market Forecast
10.2 Asia-Pacific
10.2.1 China Market Trends Market Forecast
10.2.2 Japan Market Trends Market Forecast
10.2.3 India Market Trends Market Forecast
10.2.4 South Korea Market Trends Market Forecast
10.2.5 Australia Market Trends Market Forecast
10.2.6 Indonesia Market Trends Market Forecast
10.2.7 Others Market Trends Market Forecast
10.3 Europe
10.3.1 Germany Market Trends Market Forecast
10.3.2 France Market Trends Market Forecast
10.3.3 United Kingdom Market Trends Market Forecast
10.3.4 Italy Market Trends Market Forecast
10.3.5 Spain Market Trends Market Forecast
10.3.6 Russia Market Trends Market Forecast
10.3.7 Others Market Trends Market Forecast
10.4 Latin America
10.4.1 Brazil Market Trends Market Forecast
10.4.2 Mexico Market Trends Market Forecast
10.4.3 Others Market Trends Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories Company Overview Product Portfolio Financials SWOT Analysis
15.3.2 Arkray Inc. Company Overview Product Portfolio
15.3.3 bioMérieux SA Company Overview Product Portfolio Financials SWOT Analysis
15.3.4 Bio-Rad Laboratories Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.5 DiaSorin S.p.A. Company Overview Product Portfolio Financials SWOT Analysis
15.3.6 F. Hoffmann-La Roche AG Company Overview Product Portfolio Financials
15.3.7 Immunodiagnostic Systems Holdings PLC Company Overview Product Portfolio Financials
15.3.8 Johnson & Johnson Company Overview Product Portfolio Financials SWOT Analysis
15.3.9 Siemens AG Company Overview Product Portfolio
15.3.10 Sysmex Corporation Company Overview Product Portfolio Financials SWOT Analysis
15.3.11 Thermo Fisher Scientific Inc. Company Overview Product Portfolio Financials SWOT Analysis

Companies Mentioned

  • Abbott Laboratories
  • Arkray Inc.
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche AG
  • Immunodiagnostic Systems Holdings PLC
  • Johnson & Johnson
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.



Table Information